Linked Life Data

12682260

Source:http://linkedlifedata.com/resource/pubmed/id/12682260

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12682260rdf:typepubmed:Citationlld:pubmed
pubmed-article:12682260lifeskim:mentionsumls-concept:C0032659lld:lifeskim
pubmed-article:12682260lifeskim:mentionsumls-concept:C0011306lld:lifeskim
pubmed-article:12682260lifeskim:mentionsumls-concept:C1155046lld:lifeskim
pubmed-article:12682260lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:12682260lifeskim:mentionsumls-concept:C0205216lld:lifeskim
pubmed-article:12682260lifeskim:mentionsumls-concept:C1819447lld:lifeskim
pubmed-article:12682260lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:12682260lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:12682260pubmed:issue8lld:pubmed
pubmed-article:12682260pubmed:dateCreated2003-4-8lld:pubmed
pubmed-article:12682260pubmed:abstractTextAPC infection and dysfunction may contribute to the immunopathogenesis of HIV disease. In this study, we examined immunologic function of highly enriched populations of HIV-infected monocyte-derived dendritic cells (DC). Compared with uninfected DC, HIV-infected DC markedly down-regulated surface expression of CD4. HIV p24(+) DC were then enriched by negative selection of CD4(+)HIV p24(-) DC and assessed for cytokine secretion and immunologic function. Although enriched populations of HIV-infected DC secreted increased IL-12p70 and decreased IL-10, these cells were poor stimulators of allogeneic CD4(+) T cell proliferation and IL-2 production. Interestingly, HIV-infected DC secreted HIV gp120 and the addition of soluble (s) CD4 (a known ligand for HIV gp120) to DC-CD4(+) T cell cocultures restored T cell proliferation in a dose-dependent manner. By contrast, addition of antiretroviral drugs did not affect CD4(+) T cell proliferation. Furthermore, recombinant HIV gp120 inhibited proliferation in uninfected cocultures of allogeneic DC and CD4(+) T cells, an effect that was also reversed by addition of sCD4. In summary, we show that HIV gp120 produced by DC infected by HIV in vitro impairs normal CD4(+) T cell function and that sCD4 completely reverses HIV gp120-mediated immunosuppression. We hypothesize that HIV-infected DC may contribute to impaired CD4(+) T cell-mediated immune responses in vivo and that agents that block this particular immunosuppression may be potential immune adjuvants in HIV-infected individuals.lld:pubmed
pubmed-article:12682260pubmed:languageenglld:pubmed
pubmed-article:12682260pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12682260pubmed:statusMEDLINElld:pubmed
pubmed-article:12682260pubmed:monthAprlld:pubmed
pubmed-article:12682260pubmed:issn0022-1767lld:pubmed
pubmed-article:12682260pubmed:authorpubmed-author:MitsuyaHiroak...lld:pubmed
pubmed-article:12682260pubmed:authorpubmed-author:GatanagaHiroy...lld:pubmed
pubmed-article:12682260pubmed:authorpubmed-author:ConnorsMarkMlld:pubmed
pubmed-article:12682260pubmed:authorpubmed-author:BlauveltAndre...lld:pubmed
pubmed-article:12682260pubmed:authorpubmed-author:KawamuraTatsu...lld:pubmed
pubmed-article:12682260pubmed:authorpubmed-author:BorrisDebra...lld:pubmed
pubmed-article:12682260pubmed:issnTypePrintlld:pubmed
pubmed-article:12682260pubmed:day15lld:pubmed
pubmed-article:12682260pubmed:volume170lld:pubmed
pubmed-article:12682260pubmed:ownerNLMlld:pubmed
pubmed-article:12682260pubmed:authorsCompleteYlld:pubmed
pubmed-article:12682260pubmed:pagination4260-6lld:pubmed
pubmed-article:12682260pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:meshHeadingpubmed-meshheading:12682260...lld:pubmed
pubmed-article:12682260pubmed:year2003lld:pubmed
pubmed-article:12682260pubmed:articleTitleDecreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells.lld:pubmed
pubmed-article:12682260pubmed:affiliationDermatology Branch and Experimental Retrovirology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.lld:pubmed
pubmed-article:12682260pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12682260lld:pubmed